UNITED THERAPEUTICS Corp (UTHR) › RevenueUNITED THERAPEUTICS Corp (UTHR) — RevenueAnnual figures by period end, from SEC filings.2016-12-31: $1.60B2017-12-31: $1.73B2018-12-31: $1.63B2019-12-31: $1.45B2020-12-31: $1.48B2021-12-31: $1.69B2022-12-31: $1.94B2023-12-31: $2.33B2024-12-31: $2.88B2025-12-31: $3.18B$3.18B2016-12-31Revenue (USD)2025-12-31Period endedRevenueChange YoYSource filing2025-12-31$3.18B+10.6%2026-02-25From 2025-01-012024-12-31$2.88B+23.6%2026-02-25From 2024-01-012023-12-31$2.33B+20.2%2026-02-25From 2023-01-012022-12-31$1.94B+14.9%2025-02-26From 2022-01-012021-12-31$1.69B+13.6%2024-02-21From 2021-01-012020-12-31$1.48B+2.4%2023-02-22From 2020-01-012019-12-31$1.45B-11.0%2022-02-24From 2019-01-012018-12-31$1.63B-5.7%2021-02-24From 2018-01-012017-12-31$1.73B+7.9%2020-02-26From 2017-01-012016-12-31$1.60B—2019-02-27From 2016-01-01Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)